Cys-mcMMAD is a cleavable drug-linker conjugate designed for constructing antibody-drug conjugates (ADCs). Its payload, the potent tubulin inhibitor MMAD, enables targeted cytotoxicity, making it a key reagent for ADC research in both in vitro and in vivo cancer models.